Skip to main content
Erschienen in: Internal and Emergency Medicine 2/2019

05.12.2018 | CE - LETTER TO THE EDITOR

A possible still role for colchicine in children with idiopathic recurrent acute pericarditis?

verfasst von: Giusyda Tarantino, Angelica Bibiana Delogu, Gabriella De Rosa, Donato Rigante

Erschienen in: Internal and Emergency Medicine | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi MG, Brucato A (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346CrossRefPubMed Rigante D, Cantarini L, Imazio M, Lucherini OM, Sacco E, Galeazzi M, Brizi MG, Brucato A (2011) Autoinflammatory diseases and cardiovascular manifestations. Ann Med 43:341–346CrossRefPubMed
2.
Zurück zum Zitat Rigante D, La Torraca I, Avallone L, Pugliese AL, Gaspari S, Stabile A (2006) The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci 10:173–178PubMed Rigante D, La Torraca I, Avallone L, Pugliese AL, Gaspari S, Stabile A (2006) The pharmacologic basis of treatment with colchicine in children with familial Mediterranean fever. Eur Rev Med Pharmacol Sci 10:173–178PubMed
3.
Zurück zum Zitat Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH, Adler Y, CORP (COlchicine for Recurrent Pericarditis) Investigators (2011) Colchicine for Recurrent Pericarditis (CORP): a randomized trial. Ann Intern Med 155:409–414CrossRefPubMed Imazio M, Brucato A, Cemin R, Ferrua S, Belli R, Maestroni S, Trinchero R, Spodick DH, Adler Y, CORP (COlchicine for Recurrent Pericarditis) Investigators (2011) Colchicine for Recurrent Pericarditis (CORP): a randomized trial. Ann Intern Med 155:409–414CrossRefPubMed
4.
Zurück zum Zitat Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D (2018) Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med 13:475–489CrossRefPubMed Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D (2018) Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism. Intern Emerg Med 13:475–489CrossRefPubMed
5.
Zurück zum Zitat Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W; ESC Scientific Document Group (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2964 Adler Y, Charron P, Imazio M, Badano L, Barón-Esquivias G, Bogaert J, Brucato A, Gueret P, Klingel K, Lionis C, Maisch B, Mayosi B, Pavie A, Ristic AD, Sabaté Tenas M, Seferovic P, Swedberg K, Tomkowski W; ESC Scientific Document Group (2015) 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 36:2921–2964
Metadaten
Titel
A possible still role for colchicine in children with idiopathic recurrent acute pericarditis?
verfasst von
Giusyda Tarantino
Angelica Bibiana Delogu
Gabriella De Rosa
Donato Rigante
Publikationsdatum
05.12.2018
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 2/2019
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-018-1997-5

Weitere Artikel der Ausgabe 2/2019

Internal and Emergency Medicine 2/2019 Zur Ausgabe

CE - MEDICAL ILLUSTRATION

Stevens–Johnson syndrome

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.